The clinical-trials bottleneck

Atl Mon. 1999 May;283(5):30, 32, 34, 36.
No abstract available

MeSH terms

  • Breast Neoplasms
  • Cost-Benefit Analysis
  • Decision Making
  • Drugs, Investigational*
  • Ethics Committees
  • Ethics Committees, Research
  • Financing, Government
  • Health Knowledge, Attitudes, Practice
  • Health Maintenance Organizations
  • Human Experimentation*
  • Humans
  • Insurance, Health, Reimbursement
  • Neoplasms*
  • Nontherapeutic Human Experimentation
  • Patient Advocacy
  • Patient Selection
  • Patients*
  • Physicians
  • Probability
  • Radiation
  • Random Allocation*
  • Research Subjects
  • Research*
  • Risk
  • Risk Assessment
  • Therapeutic Human Experimentation*
  • Uncertainty
  • United States

Substances

  • Drugs, Investigational